{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T21:51:27Z","timestamp":1779400287229,"version":"3.53.1"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00210-025-03985-4","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T05:58:48Z","timestamp":1741586328000},"page":"9659-9671","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Current advancement of immune function paradox of tumour-infiltrating cells and their immunotherapeutic targets: a mini-review"],"prefix":"10.1007","volume":"398","author":[{"given":"Veena V","family":"Tom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann Mary","family":"Jose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit","family":"Mallick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athira","family":"Sasidharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakshita","family":"Pawar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogish","family":"Somayaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"issue":"22","key":"3985_CR1","doi-asserted-by":"publisher","first-page":"12161","DOI":"10.3390\/ijms252212161","volume":"25","author":"E Alonso-Villa","year":"2024","unstructured":"Alonso-Villa E, Mangas A, Bonet F, Campuzano \u00d3, Quezada-Feijoo M, Ramos M, Garc\u00eda-Padilla C, Franco D, Toro R (2024) The protective role of miR-130b-3p against palmitate-induced lipotoxicity in cardiomyocytes through PPAR\u03b3 pathway. Int J Mol Sci 25(22):12161. https:\/\/doi.org\/10.3390\/ijms252212161","journal-title":"Int J Mol Sci"},{"key":"3985_CR2","doi-asserted-by":"publisher","unstructured":"Alqurashi YE (2024) Lymphocyte-activation gene 3 (LAG-3) as a promising immune checkpoint in cancer immunotherapy: from biology to the clinic. Pathol Res Pract 155124. https:\/\/doi.org\/10.1016\/j.prp.2024.155124","DOI":"10.1016\/j.prp.2024.155124"},{"issue":"2","key":"3985_CR3","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/JLB.1MR0120-196R","volume":"108","author":"F Alvarez","year":"2020","unstructured":"Alvarez F, Al-Aubodah TA, Yang YH, Piccirillo CA (2020) Mechanisms of TREG cell adaptation to inflammation. J Leukoc Biol 108(2):559\u2013571. https:\/\/doi.org\/10.1002\/JLB.1MR0120-196R","journal-title":"J Leukoc Biol"},{"issue":"3","key":"3985_CR4","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/1878-0261.12616","volume":"14","author":"A Arlt","year":"2020","unstructured":"Arlt A, von Bonin F, Rehberg T, Perez-Rubio P, Engelmann JC, Limm K, Reinke S, Dullin C, Sun X, Specht R, Maulhardt M (2020) High CD206 levels in Hodgkin lymphoma-educated macrophages are linked to matrix-remodeling and lymphoma dissemination. Mol Oncol 14(3):571\u2013589. https:\/\/doi.org\/10.1002\/1878-0261.12616","journal-title":"Mol Oncol"},{"issue":"9","key":"3985_CR5","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.3390\/biom12091282","volume":"12","author":"L Bai","year":"2022","unstructured":"Bai L, Hao X, Keith J, Feng Y (2022) DNA methylation in regulatory T cell differentiation and function: challenges and opportunities. Biomolecules 12(9):1282. https:\/\/doi.org\/10.3390\/biom12091282","journal-title":"Biomolecules"},{"issue":"7","key":"3985_CR6","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41568-023-00574-6","volume":"23","author":"B Banushi","year":"2023","unstructured":"Banushi B, Joseph SR, Lum B, Lee JJ, Simpson F (2023) Endocytosis in cancer and cancer therapy. Nat Rev Cancer 23(7):450\u2013473. https:\/\/doi.org\/10.1038\/s41568-023-00574-6","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"3985_CR7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/imr.13262","volume":"318","author":"SM Blum","year":"2023","unstructured":"Blum SM, Rouhani SJ, Sullivan RJ (2023) Effects of immune-related adverse events (irAEs) and their treatment on antitumor immune responses. Immunol Rev 318(1):167\u2013178. https:\/\/doi.org\/10.1111\/imr.13262","journal-title":"Immunol Rev"},{"key":"3985_CR8","doi-asserted-by":"publisher","unstructured":"Bufalino A (2025) Host defences against cancer. Pathological Basis of Oral and Maxillofacial Diseases. 429\u201339. https:\/\/doi.org\/10.1002\/9781119989233.ch25","DOI":"10.1002\/9781119989233.ch25"},{"issue":"10","key":"3985_CR9","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.32604\/or.2024.043987","volume":"32","author":"S Chandra","year":"2024","unstructured":"Chandra S, Wilson JC, Good D, Wei MQ (2024) mRNA vaccines: a new era in vaccine development. Oncol Res 32(10):1543. https:\/\/doi.org\/10.32604\/or.2024.043987","journal-title":"Oncol Res"},{"issue":"5","key":"3985_CR10","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.3390\/cells9051098","volume":"9","author":"YM Chen","year":"2020","unstructured":"Chen YM, Qi S, Perrino S, Hashimoto M, Brodt P (2020) Targeting the IGF-axis for cancer therapy: development and validation of an IGF-trap as a potential drug. Cells 9(5):1098. https:\/\/doi.org\/10.3390\/cells9051098","journal-title":"Cells"},{"key":"3985_CR11","doi-asserted-by":"publisher","first-page":"e16825","DOI":"10.7717\/peerj.16825","volume":"12","author":"H Cheng","year":"2024","unstructured":"Cheng H, Zheng Y (2024) Advances in macrophage and T cell metabolic reprogramming and immunotherapy in the tumor microenvironment. PeerJ 12:e16825. https:\/\/doi.org\/10.7717\/peerj.16825","journal-title":"PeerJ"},{"key":"3985_CR12","doi-asserted-by":"publisher","unstructured":"Contreras-Castillo E, Garc\u00eda-Rasilla VY, Garc\u00eda-Pati\u00f1o MG, Licona-Lim\u00f3n P (2024) Stability and plasticity of regulatory T cells in health and disease. J Leukoc Biol. qiae049. https:\/\/doi.org\/10.1093\/jleuko\/qiae049","DOI":"10.1093\/jleuko\/qiae049"},{"key":"3985_CR13","doi-asserted-by":"publisher","first-page":"675099","DOI":"10.3389\/fcell.2021.675099","volume":"9","author":"KF Corral-Jara","year":"2021","unstructured":"Corral-Jara KF, Rosas da Silva G, Fierro NA, Soumelis V (2021) Modeling the Th17 and tregs paradigm: implications for cancer immunotherapy. Front Cell Dev Biol 9:675099. https:\/\/doi.org\/10.3389\/fcell.2021.675099","journal-title":"Front Cell Dev Biol"},{"issue":"7","key":"3985_CR14","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.3390\/cells12071047","volume":"12","author":"VA Cort\u00e9s-Morales","year":"2023","unstructured":"Cort\u00e9s-Morales VA, Ch\u00e1vez-S\u00e1nchez L, Rocha-Zavaleta L, Esp\u00edndola-Garibay S, Monroy-Garc\u00eda A, Castro-Manrreza ME, Fajardo-Ordu\u00f1a GR, Apresa-Garc\u00eda T, Guti\u00e9rrez-de la Barrera M, Mayani H, Montesinos JJ (2023) Mesenchymal stem\/stromal cells derived from cervical cancer promote M2 macrophage polarization. Cells. 12(7):1047. https:\/\/doi.org\/10.3390\/cells12071047","journal-title":"Cells."},{"key":"3985_CR15","doi-asserted-by":"publisher","first-page":"116203","DOI":"10.1016\/j.biopha.2024.116203","volume":"171","author":"JW Cui","year":"2024","unstructured":"Cui JW, Li Y, Yang Y, Yang HK, Dong JM, Xiao ZH, He X, Guo JH, Wang RQ, Dai B, Zhou ZL (2024) Tumor immunotherapy resistance: revealing the mechanism of PD-1\/PD-L1-mediated tumor immune escape. Biomed Pharmacother 171:116203. https:\/\/doi.org\/10.1016\/j.biopha.2024.116203","journal-title":"Biomed Pharmacother"},{"key":"3985_CR16","doi-asserted-by":"publisher","first-page":"1200646","DOI":"10.3389\/fonc.2023.1200646","volume":"13","author":"P Czajka-Francuz","year":"2023","unstructured":"Czajka-Francuz P, Prendes MJ, Mankan A, Quintana A, Pabla S, Ramkissoon S, Jensen TJ, Peiro S, Severson EA, Achyut BR, Vidal L (2023) Mechanisms of immune modulation in the tumor microenvironment and implications for targeted therapy. Front Oncol 13:1200646. https:\/\/doi.org\/10.3389\/fonc.2023.1200646","journal-title":"Front Oncol"},{"issue":"14","key":"3985_CR17","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.3390\/ijms20143478","volume":"20","author":"MJ Dabrowski","year":"2019","unstructured":"Dabrowski MJ, Wojtas B (2019) Global DNA methylation patterns in human gliomas and their interplay with other epigenetic modifications. Int J Mol Sci 20(14):3478. https:\/\/doi.org\/10.3390\/ijms20143478","journal-title":"Int J Mol Sci"},{"issue":"19","key":"3985_CR18","doi-asserted-by":"publisher","first-page":"7356","DOI":"10.3390\/ijms21197356","volume":"21","author":"H Dai","year":"2020","unstructured":"Dai H, Xu H, Wang S, Ma J (2020) Connections between metabolism and epigenetic modification in MDSCs. Int J Mol Sci 21(19):7356. https:\/\/doi.org\/10.3390\/ijms21197356","journal-title":"Int J Mol Sci"},{"key":"3985_CR19","doi-asserted-by":"publisher","unstructured":"Di Mauro F, Arbore G (2024) Spatial dissection of the immune landscape of solid tumors to advance precision medicine. Cancer Immunol Res OF1\u20134. https:\/\/doi.org\/10.1158\/2326-6066.CIR-23-0699","DOI":"10.1158\/2326-6066.CIR-23-0699"},{"key":"3985_CR20","doi-asserted-by":"publisher","first-page":"1213320","DOI":"10.3389\/fmed.2023.1213320","volume":"10","author":"K Dileepan","year":"2023","unstructured":"Dileepan K, Raveendran VV, Sharma R, Abraham H, Barua R, Singh V, Sharma R, Sharma M (2023) Mast cell-mediated immune regulation in health and disease. Front Med 10:1213320. https:\/\/doi.org\/10.3389\/fmed.2023.1213320","journal-title":"Front Med"},{"issue":"8","key":"3985_CR21","doi-asserted-by":"publisher","first-page":"10564","DOI":"10.1021\/acsami.0c20254","volume":"13","author":"S Ding","year":"2021","unstructured":"Ding S, Liu Z, Huang C, Zeng N, Jiang W, Li Q (2021) Novel engineered bacterium\/black phosphorus quantum dot hybrid system for hypoxic tumor targeting and efficient photodynamic therapy. ACS Appl Mater Interfaces 13(8):10564\u201310573. https:\/\/doi.org\/10.1021\/acsami.0c20254","journal-title":"ACS Appl Mater Interfaces"},{"issue":"93","key":"3985_CR22","doi-asserted-by":"publisher","first-page":"eadf2223","DOI":"10.1126\/sciimmunol.adf2223","volume":"9","author":"KO Dixon","year":"2024","unstructured":"Dixon KO, Lahore GF, Kuchroo VK (2024) Beyond T cell exhaustion: TIM-3 regulation of myeloid cells. Sci Immunol 9(93):eadf2223. https:\/\/doi.org\/10.1126\/sciimmunol.adf2223","journal-title":"Sci Immunol"},{"key":"3985_CR23","doi-asserted-by":"publisher","first-page":"626172","DOI":"10.3389\/fimmu.2021.626172","volume":"12","author":"Y Dong","year":"2021","unstructured":"Dong Y, Yang C, Pan F (2021) Post-translational regulations of Foxp3 in Treg cells and their therapeutic applications. Front Immunol 12:626172. https:\/\/doi.org\/10.3389\/fimmu.2021.626172","journal-title":"Front Immunol"},{"issue":"1","key":"3985_CR24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12967-024-05888-z","volume":"23","author":"Y Dong","year":"2025","unstructured":"Dong Y, Cheng A, Zhou J, Guo J, Liu Y, Li X, Chen M, Hu D, Wu J (2025) PRDX2 induces tumor immune evasion by modulating the HDAC3-Galectin-9 axis in lung adenocarcinoma cells. J Transl Med 23(1):81. https:\/\/doi.org\/10.1186\/s12967-024-05888-z","journal-title":"J Transl Med"},{"issue":"7","key":"3985_CR25","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.trecan.2020.02.022","volume":"6","author":"Q Duan","year":"2020","unstructured":"Duan Q, Zhang H, Zheng J, Zhang L (2020) Turning cold into hot: firing up the tumor microenvironment. Trends Cancer 6(7):605\u2013618. https:\/\/doi.org\/10.1016\/j.trecan.2020.02.022","journal-title":"Trends Cancer"},{"issue":"1","key":"3985_CR26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3390\/cancers15164188","volume":"2","author":"BC Duarte","year":"2024","unstructured":"Duarte BC, do Amaral LR, Bertarini PL, de Souza Gomes M, Queiroz FR, da Concei\u00e7\u00e3o Braga L (2024) Decoding the cancer code: unveiling the potential of long non-coding rnas in oncology. M\u00e1rio Penna J. 2(1):68\u201399. https:\/\/doi.org\/10.3390\/cancers15164188","journal-title":"M\u00e1rio Penna J."},{"issue":"1_Supplement","key":"3985_CR27","doi-asserted-by":"publisher","first-page":"76","DOI":"10.4049\/jimmunol.210.Supp.76.16","volume":"210","author":"C Elkins","year":"2023","unstructured":"Elkins C, Sivasami P, Bae J, Li C (2023) Cellular cholesterol homeostasis supports visceral adipose tissue (VAT) regulatory T cell (Treg) accumulation and promotes metabolic health. J Immunol 210(1_Supplement):76\u201316. https:\/\/doi.org\/10.4049\/jimmunol.210.Supp.76.16","journal-title":"J Immunol"},{"issue":"3","key":"3985_CR28","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.3390\/ijms24032413","volume":"24","author":"IY Filin","year":"2023","unstructured":"Filin IY, Mayasin YP, Kharisova CB, Gorodilova AV, Kitaeva KV, Chulpanova DS, Solovyeva VV, Rizvanov AA (2023) Cell immunotherapy against melanoma: clinical trials review. Int J Mol Sci 24(3):2413. https:\/\/doi.org\/10.3390\/ijms24032413","journal-title":"Int J Mol Sci"},{"issue":"23","key":"3985_CR29","doi-asserted-by":"publisher","first-page":"12848","DOI":"10.3390\/ijms252312848","volume":"25","author":"O Franzese","year":"2024","unstructured":"Franzese O (2024) Tumor microenvironment drives the cross-talk between co-stimulatory and inhibitory molecules in tumor-infiltrating lymphocytes: implications for optimizing immunotherapy outcomes. Int J Mol Sci 25(23):12848. https:\/\/doi.org\/10.3390\/ijms252312848","journal-title":"Int J Mol Sci"},{"key":"3985_CR30","doi-asserted-by":"publisher","unstructured":"Friedman MJ, Lee H, Lee JY, Oh S (2023) Transcriptional and epigenetic regulation of context-dependent plasticity in T-helper lineages. Immune Netw 23(1). https:\/\/doi.org\/10.4110\/in.2023.23.e5","DOI":"10.4110\/in.2023.23.e5"},{"key":"3985_CR31","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3389\/fimmu.2020.00835","volume":"11","author":"W Fu","year":"2020","unstructured":"Fu W, Wang W, Li H, Jiao Y, Huo R, Yan Z, Wang J, Wang S, Wang J, Chen D, Cao Y (2020) Single-cell atlas reveals complexity of the immunosuppressive microenvironment of initial and recurrent glioblastoma. Front Immunol 11:835. https:\/\/doi.org\/10.3389\/fimmu.2020.00835","journal-title":"Front Immunol"},{"key":"3985_CR32","doi-asserted-by":"publisher","first-page":"699895","DOI":"10.3389\/fimmu.2021.699895","volume":"12","author":"Z Ge","year":"2021","unstructured":"Ge Z, Peppelenbosch MP, Sprengers D, Kwekkeboom J (2021) TIGIT, the next step towards successful combination immune checkpoint therapy in cancer. Front Immunol 12:699895. https:\/\/doi.org\/10.3389\/fimmu.2021.699895","journal-title":"Front Immunol"},{"issue":"1","key":"3985_CR33","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3390\/ijms25063178","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, Foo AS, Lam HY, Yap KC, Jacot W, Jones RH, Eng H, Nair MG, Makvandi P, Geoerger B, Kulke MH (2023) PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer 22(1):138. https:\/\/doi.org\/10.3390\/ijms25063178","journal-title":"Mol Cancer"},{"issue":"2","key":"3985_CR34","doi-asserted-by":"publisher","first-page":"2350778","DOI":"10.1002\/eji.202350778","volume":"54","author":"C Guo","year":"2024","unstructured":"Guo C, Liu J, Zhang Y (2024) Current advances in bacteria-based cancer immunotherapy. Eur J Immunol 54(2):2350778. https:\/\/doi.org\/10.1002\/eji.202350778","journal-title":"Eur J Immunol"},{"key":"3985_CR35","doi-asserted-by":"publisher","unstructured":"Gupta MK, Vadde R (2025) Tumor microenvironment of colorectal cancer. InImmune Therapy for Pancreatic and Colon Cancers. Academic Press, pp 67\u201384. https:\/\/doi.org\/10.1016\/B978-0-443-24742-2.00024-1","DOI":"10.1016\/B978-0-443-24742-2.00024-1"},{"issue":"9","key":"3985_CR36","doi-asserted-by":"publisher","first-page":"2250002","DOI":"10.1002\/eji.202250002","volume":"53","author":"T Halvorson","year":"2023","unstructured":"Halvorson T, Tuomela K, Levings MK (2023) Targeting regulatory T cell metabolism in disease: novel therapeutic opportunities. Eur J Immunol 53(9):2250002. https:\/\/doi.org\/10.1002\/eji.202250002","journal-title":"Eur J Immunol"},{"issue":"1","key":"3985_CR37","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/s0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57\u201370. https:\/\/doi.org\/10.1016\/s0092-8674(00)81683-9","journal-title":"Cell"},{"key":"3985_CR38","doi-asserted-by":"publisher","first-page":"1005566","DOI":"10.3389\/fonc.2022.1005566","volume":"12","author":"A Hashimoto","year":"2022","unstructured":"Hashimoto A, Handa H, Hata S, Hashimoto S (2022) Orchestration of mesenchymal plasticity and immune evasiveness via rewiring of the metabolic program in pancreatic ductal adenocarcinoma. Front Oncol 12:1005566. https:\/\/doi.org\/10.3389\/fonc.2022.1005566","journal-title":"Front Oncol"},{"key":"3985_CR39","doi-asserted-by":"publisher","first-page":"741305","DOI":"10.3389\/fimmu.2021.741305","volume":"12","author":"Z He","year":"2021","unstructured":"He Z, Zhang S (2021) Tumor-associated macrophages and their functional transformation in the hypoxic tumor microenvironment. Front Immunol 12:741305. https:\/\/doi.org\/10.3389\/fimmu.2021.741305","journal-title":"Front Immunol"},{"issue":"10","key":"3985_CR40","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.3390\/cells10102700","volume":"10","author":"F Hofer","year":"2021","unstructured":"Hofer F, Di Sario G, Musiu C, Sartoris S, De Sanctis F, Ugel S (2021) A complex metabolic network confers immunosuppressive functions to myeloid-derived suppressor cells (MDSCs) within the tumour microenvironment. Cells 10(10):2700. https:\/\/doi.org\/10.3390\/cells10102700","journal-title":"Cells"},{"issue":"24","key":"3985_CR41","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1097\/CM9.0000000000003455","volume":"137","author":"S Huang","year":"2024","unstructured":"Huang S, Que H, Wang M, Wei X (2024) mRNA vaccines as cancer therapies. Chin Med J 137(24):2979\u20132995. https:\/\/doi.org\/10.1097\/CM9.0000000000003455","journal-title":"Chin Med J"},{"key":"3985_CR42","doi-asserted-by":"publisher","unstructured":"Ikeda H (2025) Cancer immunotherapy in progress\u2014an overview of the past 130 years. Int Immunol. 10:dxaf002.\u00a0https:\/\/doi.org\/10.1093\/intimm\/dxaf002","DOI":"10.1093\/intimm\/dxaf002"},{"key":"3985_CR43","unstructured":"Immune Deficiency Foundation (2025) Immune system and PI. Primary immune deficiency foundation. Retrieved from https:\/\/primaryimmune.org\/understanding-primary-immunodeficiency\/what-is-pi\/immune-system-and-pi. Accessed 26 Jan 2025"},{"issue":"5","key":"3985_CR44","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1089\/genbio.2023.0029","volume":"2","author":"N Jhaveri","year":"2023","unstructured":"Jhaveri N, Ben Cheikh B, Nikulina N, Ma N, Klymyshyn D, DeRosa J, Mihani R, Pratapa A, Kassim Y, Bommakanti S, Shang O (2023) Mapping the spatial proteome of head and neck tumors: key immune mediators and metabolic determinants in the tumor microenvironment. GEN Biotechnol 2(5):418\u2013434. https:\/\/doi.org\/10.1089\/genbio.2023.0029","journal-title":"GEN Biotechnol"},{"issue":"1","key":"3985_CR45","doi-asserted-by":"publisher","first-page":"155","DOI":"10.7150\/thno.103376","volume":"15","author":"M Jiang","year":"2025","unstructured":"Jiang M, Fang H, Tian H (2025) Metabolism of cancer cells and immune cells in the initiation, progression, and metastasis of cancer. Theranostics 15(1):155. https:\/\/doi.org\/10.7150\/thno.103376","journal-title":"Theranostics"},{"issue":"7","key":"3985_CR46","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.4049\/jimmunol.2000612","volume":"205","author":"DM Jones","year":"2020","unstructured":"Jones DM, Read KA, Oestreich KJ (2020) Dynamic roles for IL-2\u2013STAT5 signaling in effector and regulatory CD4+ T cell populations. J Immunol 205(7):1721\u20131730. https:\/\/doi.org\/10.4049\/jimmunol.2000612","journal-title":"J Immunol"},{"key":"3985_CR47","doi-asserted-by":"publisher","unstructured":"Kendsersky NM, Odrobina M, Mabe NW, Farrel A, Grossmann L, Tsang M, Groff D, Wolpaw AJ, Narch A, Zammarchi F, van Berkel PH (2025) Lineage-dependence of the neuroblastoma surfaceome defines tumor cell state-dependent and independent immunotherapeutic targets. Neuro-Oncology. noaf012. https:\/\/doi.org\/10.1101\/2024.06.27.600865","DOI":"10.1101\/2024.06.27.600865"},{"key":"3985_CR48","doi-asserted-by":"publisher","first-page":"656364","DOI":"10.3389\/fimmu.2021.656364","volume":"12","author":"K Khalaf","year":"2021","unstructured":"Khalaf K, Hana D, Chou JT, Singh C, Mackiewicz A, Kaczmarek M (2021) Aspects of the tumor microenvironment involved in immune resistance and drug resistance. Front Immunol 12:656364. https:\/\/doi.org\/10.3389\/fimmu.2021.656364","journal-title":"Front Immunol"},{"issue":"4","key":"3985_CR49","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1002\/vms3.1161","volume":"9","author":"D Khayatan","year":"2023","unstructured":"Khayatan D, Hussain A, Tebyaniyan H (2023) Exploring animal models in oral cancer research and clinical intervention: a critical review. Vet Med Sci 9(4):1833\u20131847. https:\/\/doi.org\/10.1002\/vms3.1161","journal-title":"Vet Med Sci"},{"key":"3985_CR50","doi-asserted-by":"publisher","first-page":"636081","DOI":"10.3389\/fimmu.2021.636081","volume":"12","author":"M Kim","year":"2021","unstructured":"Kim M, Tomek P (2021) Tryptophan: a rheostat of cancer immune escape mediated by immunosuppressive enzymes IDO1 and TDO. Front Immunol 12:636081. https:\/\/doi.org\/10.3389\/fimmu.2021.636081","journal-title":"Front Immunol"},{"issue":"23","key":"3985_CR51","doi-asserted-by":"publisher","first-page":"7837","DOI":"10.3390\/molecules28237837","volume":"28","author":"M K\u0142\u00f3sek","year":"2023","unstructured":"K\u0142\u00f3sek M, Krawczyk-\u0141ebek A, Kostrzewa-Sus\u0142ow E, Szliszka E, Bronikowska J, Jaworska D, Pietsz G, Czuba ZP (2023) In vitro anti-inflammatory activity of methyl derivatives of flavanone. Molecules 28(23):7837. https:\/\/doi.org\/10.3390\/molecules28237837","journal-title":"Molecules"},{"issue":"12","key":"3985_CR52","doi-asserted-by":"publisher","first-page":"4427","DOI":"10.3390\/ijms21124427","volume":"21","author":"O Kooshkaki","year":"2020","unstructured":"Kooshkaki O, Derakhshani A, Hosseinkhani N, Torabi M, Safaei S, Brunetti O, Racanelli V, Silvestris N, Baradaran B (2020) Combination of ipilimumab and nivolumab in cancers: from clinical practice to ongoing clinical trials. Int J Mol Sci 21(12):4427. https:\/\/doi.org\/10.3390\/ijms21124427","journal-title":"Int J Mol Sci"},{"issue":"9","key":"3985_CR53","doi-asserted-by":"publisher","first-page":"4832","DOI":"10.3390\/ijms25094832","volume":"25","author":"A Kotsifaki","year":"2024","unstructured":"Kotsifaki A, Maroulaki S, Armakolas A (2024) Exploring the immunological profile in breast cancer: recent advances in diagnosis and prognosis through circulating tumor cells. Int J Mol Sci 25(9):4832. https:\/\/doi.org\/10.3390\/ijms25094832","journal-title":"Int J Mol Sci"},{"key":"3985_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-019-1266-0","volume":"38","author":"S Kruger","year":"2019","unstructured":"Kruger S, Ilmer M, Kobold S, Cadilha BL, Endres S, Ormanns S, Schuebbe G, Renz BW, D\u2019Haese JG, Schloesser H, Heinemann V (2019) Advances in cancer immunotherapy 2019\u2013latest trends. J Exp Clin Cancer Res 38:1\u20131. https:\/\/doi.org\/10.1186\/s13046-019-1266-0","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"3985_CR55","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.3390\/cancers12051089","volume":"12","author":"M Kudo","year":"2020","unstructured":"Kudo M (2020) Scientific rationale for combined immunotherapy with PD-1\/PD-L1 antibodies and VEGF inhibitors in advanced hepatocellular carcinoma. Cancers 12(5):1089. https:\/\/doi.org\/10.3390\/cancers12051089","journal-title":"Cancers"},{"issue":"21","key":"3985_CR56","doi-asserted-by":"publisher","first-page":"5224","DOI":"10.3390\/cancers14215224","volume":"14","author":"S Kumar","year":"2022","unstructured":"Kumar S, Mittal S, Gupta P, Singh M, Chaluvally-Raghavan P, Pradeep S (2022) Metabolic reprogramming in tumor-associated macrophages in the ovarian tumor microenvironment. Cancers 14(21):5224. https:\/\/doi.org\/10.3390\/cancers14215224","journal-title":"Cancers"},{"issue":"6","key":"3985_CR57","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1038\/s41401-021-00776-4","volume":"43","author":"Q Li","year":"2022","unstructured":"Li Q, Xiang M (2022) Metabolic reprograming of MDSCs within tumor microenvironment and targeting for cancer immunotherapy. Acta Pharmacol Sin 43(6):1337\u20131348. https:\/\/doi.org\/10.1038\/s41401-021-00776-4","journal-title":"Acta Pharmacol Sin"},{"issue":"7","key":"3985_CR58","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41571-019-0203-7","volume":"16","author":"X Li","year":"2019","unstructured":"Li X, Wenes M, Romero P, Huang SC, Fendt SM, Ho PC (2019) Navigating metabolic pathways to enhance antitumour immunity and immunotherapy. Nat Rev Clin Oncol 16(7):425\u2013441. https:\/\/doi.org\/10.1038\/s41571-019-0203-7","journal-title":"Nat Rev Clin Oncol"},{"key":"3985_CR59","doi-asserted-by":"publisher","first-page":"747863","DOI":"10.3389\/fcell.2021.747863","volume":"9","author":"J Li","year":"2021","unstructured":"Li J, Bolyard C, Xin G, Li Z (2021) Targeting metabolic pathways of myeloid cells improves cancer immunotherapy. Front Cell Dev Biol 9:747863. https:\/\/doi.org\/10.3389\/fcell.2021.747863","journal-title":"Front Cell Dev Biol"},{"key":"3985_CR60","doi-asserted-by":"publisher","first-page":"1166860","DOI":"10.3389\/fonc.2023.1166860","volume":"13","author":"Y Li","year":"2023","unstructured":"Li Y, Xiang S, Pan W, Wang J, Zhan H, Liu S (2023) Targeting tumor immunosuppressive microenvironment for pancreatic cancer immunotherapy: current research and future perspective. Front Oncol 13:1166860. https:\/\/doi.org\/10.3389\/fonc.2023.1166860","journal-title":"Front Oncol"},{"key":"3985_CR61","doi-asserted-by":"publisher","unstructured":"Li J, Yu H, Kang Y, Niu K, Wang M, Jiang Y, Jiang N, Ding Z, Gan Z, Yu Q (2024) STING membrane prevents post\u2010surgery tissue adhesion and tumor recurrence of colorectal cancer. Adv Mater 2309655. https:\/\/doi.org\/10.1002\/adma.202309655","DOI":"10.1002\/adma.202309655"},{"issue":"1","key":"3985_CR62","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41392-024-01955-5","volume":"9","author":"Z Liu","year":"2024","unstructured":"Liu Z, Chen J, Ren Y, Liu S, Ba Y, Zuo A, Luo P, Cheng Q, Xu H, Han X (2024a) Multi-stage mechanisms of tumor metastasis and therapeutic strategies. Signal Transduct Target Ther 9(1):270. https:\/\/doi.org\/10.1038\/s41392-024-01955-5","journal-title":"Signal Transduct Target Ther"},{"key":"3985_CR63","doi-asserted-by":"publisher","first-page":"1514595","DOI":"10.3389\/fcell.2024.1514595","volume":"12","author":"Y Liu","year":"2024","unstructured":"Liu Y, Liu F, Zeng Y, Lin L, Yu H, Zhang S, Yang W (2024b) Hydrogel systems for spatiotemporal controlled delivery of immunomodulators: engineering the tumor immune microenvironment for enhanced cancer immunotherapy. Front Cell Dev Biol 12:1514595. https:\/\/doi.org\/10.3389\/fcell.2024.1514595","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"3985_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-024-02165-x","volume":"23","author":"S Liu","year":"2024","unstructured":"Liu S, Zhang X, Wang W, Li X, Sun X, Zhao Y, Wang Q, Li Y, Hu F, Ren H (2024c) Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer. Mol Cancer 23(1):1\u201357. https:\/\/doi.org\/10.1186\/s12943-024-02165-x","journal-title":"Mol Cancer"},{"key":"3985_CR65","doi-asserted-by":"publisher","unstructured":"Lopez de Rodas M, Villalba-Esparza M, Sanmamed MF, Chen L, Rimm DL, Schalper KA (2025) Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy: a multidimensional approach. Nat Rev Clin Oncol. 1\u20139. https:\/\/doi.org\/10.1038\/s41571-024-00984-x","DOI":"10.1038\/s41571-024-00984-x"},{"key":"3985_CR66","doi-asserted-by":"publisher","unstructured":"Lu C, Tan Y (2024) Promising immunotherapy targets: TIM3, LAG3, and TIGIT joined the party. Mol Ther Oncol 32(1). https:\/\/doi.org\/10.1016\/j.omton.2024.200773","DOI":"10.1016\/j.omton.2024.200773"},{"key":"3985_CR67","doi-asserted-by":"publisher","first-page":"1278560","DOI":"10.3389\/fimmu.2023.1278560.z","volume":"14","author":"Z Luo","year":"2023","unstructured":"Luo Z, Zhang Y, Saleh QW, Zhang J, Zhu Z, Tepel M (2023) Metabolic regulation of forkhead box P3 alternative splicing isoforms and their impact on health and disease. Front Immunol 14:1278560. https:\/\/doi.org\/10.3389\/fimmu.2023.1278560.z","journal-title":"Front Immunol"},{"key":"3985_CR68","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s11060-021-03721-x","volume":"152","author":"MJ Mair","year":"2021","unstructured":"Mair MJ, Kiesel B, Feldmann K, Widhalm G, Dieckmann K, W\u00f6hrer A, M\u00fcllauer L, Preusser M, Berghoff AS (2021) LAG-3 expression in the inflammatory microenvironment of glioma. J Neurooncol 152:533\u2013539. https:\/\/doi.org\/10.1007\/s11060-021-03721-x","journal-title":"J Neurooncol"},{"key":"3985_CR69","doi-asserted-by":"publisher","unstructured":"Mallick S, Duttaroy AK, Bose B (2024) A snapshot of cytokine dynamics: a fine balance between health and disease. J Cell Biochem. e30680. https:\/\/doi.org\/10.1002\/jcb.30680","DOI":"10.1002\/jcb.30680"},{"issue":"1","key":"3985_CR70","doi-asserted-by":"publisher","first-page":"21710","DOI":"10.1038\/s41598-024-72492-y","volume":"14","author":"A Markovska","year":"2024","unstructured":"Markovska A, Somers K, Guillaume J, Melief J, Mazar AP, Schmitt DM, Schipper HS, Boes M (2024) Targeted inhibition of glycogen synthase kinase-3 using 9-ING-41 (elraglusib) enhances CD8 T-cell-reactivity against neuroblastoma cells. Sci Rep 14(1):21710. https:\/\/doi.org\/10.1038\/s41598-024-72492-y","journal-title":"Sci Rep"},{"key":"3985_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13223-018-0278-1","volume":"14","author":"JS Marshall","year":"2018","unstructured":"Marshall JS, Warrington R, Watson W, Kim HL (2018) An introduction to immunology and immunopathology. Allergy Asthma Clin Immunol 14:1. https:\/\/doi.org\/10.1186\/s13223-018-0278-1","journal-title":"Allergy Asthma Clin Immunol"},{"key":"3985_CR72","unstructured":"Martin M (n.d.) KRAS Driven Mouse Model of Preinvasive to Invasive Lung Adenocarcinoma\u00a0(Doctoral dissertation, Weill Medical College of Cornell University)"},{"issue":"2","key":"3985_CR73","doi-asserted-by":"publisher","first-page":"789","DOI":"10.7150\/ijbs.106115","volume":"21","author":"X Meng","year":"2025","unstructured":"Meng X, Luo Y, Cui L, Wang S (2025) Involvement of Tim-3 in maternal-fetal tolerance: a review of current understanding. Int J Biol Sci 21(2):789. https:\/\/doi.org\/10.7150\/ijbs.106115","journal-title":"Int J Biol Sci"},{"issue":"1","key":"3985_CR74","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/cancers17010019","volume":"17","author":"A Merenstein","year":"2024","unstructured":"Merenstein A, Obeidat L, Zaravinos A, Bonavida B (2024) The role of YY1 in the regulation of LAG-3 expression in CD8 T cells and immune evasion in cancer: therapeutic implications. Cancers 17(1):19. https:\/\/doi.org\/10.3390\/cancers17010019","journal-title":"Cancers"},{"issue":"1","key":"3985_CR75","doi-asserted-by":"publisher","first-page":"1886844","DOI":"10.1080\/19490976.2021.1886844","volume":"13","author":"AH Mohseni","year":"2021","unstructured":"Mohseni AH, Casolaro V, Berm\u00fadez-Humar\u00e1n LG, Keyvani H, Taghinezhad-S S (2021) Modulation of the PI3K\/Akt\/mTOR signaling pathway by probiotics as a fruitful target for orchestrating the immune response. Gut Microbes 13(1):1886844. https:\/\/doi.org\/10.1080\/19490976.2021.1886844","journal-title":"Gut Microbes"},{"key":"3985_CR76","doi-asserted-by":"publisher","first-page":"114824","DOI":"10.1016\/j.biopha.2023.114824","volume":"163","author":"K Mortezaee","year":"2023","unstructured":"Mortezaee K, Majidpoor J (2023) Mechanisms of CD8+ T cell exclusion and dysfunction in cancer resistance to anti-PD-(L) 1. Biomed Pharmacother 163:114824. https:\/\/doi.org\/10.1016\/j.biopha.2023.114824","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"3985_CR77","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4049\/immunohorizons.1700004","volume":"1","author":"MG Morvan","year":"2017","unstructured":"Morvan MG, Champsaur M, Reizis B, Lanier LL (2017) Chronic in vivo interaction of dendritic cells expressing the ligand Rae-1\u03b5 with NK cells impacts NKG2D expression and function. Immunohorizons 1(3):10\u201319. https:\/\/doi.org\/10.4049\/immunohorizons.1700004","journal-title":"Immunohorizons"},{"key":"3985_CR78","doi-asserted-by":"publisher","unstructured":"M\u00fclling N, Behr FM, Heieis GA, Boss K, van Duikeren S, van Haften FJ, Pardieck IN, van der Gracht ET, Vleeshouwers W, van der Sluis TC, de Graaf JF (2024) Inhibiting the NADase CD38 improves cytomegalovirus-specific CD8+ T cell functionality and metabolism. J Clin Investig 134(17). https:\/\/doi.org\/10.1172\/JCI179561","DOI":"10.1172\/JCI179561"},{"key":"3985_CR79","doi-asserted-by":"publisher","first-page":"1353787","DOI":"10.3389\/fimmu.2024.1353787","volume":"15","author":"A Nicolini","year":"2024","unstructured":"Nicolini A, Ferrari P (2024) Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy. Front Immunol 15:1353787. https:\/\/doi.org\/10.3389\/fimmu.2024.1353787","journal-title":"Front Immunol"},{"issue":"7","key":"3985_CR80","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.3390\/cancers13071552","volume":"13","author":"C Ollauri-Ib\u00e1\u00f1ez","year":"2021","unstructured":"Ollauri-Ib\u00e1\u00f1ez C, Ayuso-\u00cd\u00f1igo B, Pericacho M (2021) Hot and cold tumors: is endoglin (CD105) a potential target for vessel normalization? Cancers 13(7):1552. https:\/\/doi.org\/10.3390\/cancers13071552","journal-title":"Cancers"},{"issue":"7","key":"3985_CR81","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.3390\/antiox11071394","volume":"11","author":"S P\u00e9rez","year":"2022","unstructured":"P\u00e9rez S, Rius-P\u00e9rez S (2022) Macrophage polarization and reprogramming in acute inflammation: a redox perspective. Antioxidants 11(7):1394. https:\/\/doi.org\/10.3390\/antiox11071394","journal-title":"Antioxidants"},{"key":"3985_CR82","doi-asserted-by":"publisher","first-page":"1325255","DOI":"10.3389\/fimmu.2023.1325255","volume":"14","author":"N Poveda-Garavito","year":"2024","unstructured":"Poveda-Garavito N, Combita AL (2024) Contribution of the TIME in BCP-ALL: the basis for novel approaches therapeutics. Front Immunol 14:1325255. https:\/\/doi.org\/10.3389\/fimmu.2023.1325255","journal-title":"Front Immunol"},{"key":"3985_CR83","doi-asserted-by":"publisher","first-page":"103773","DOI":"10.1016\/j.critrevonc.2022.103773","volume":"177","author":"D Presti","year":"2022","unstructured":"Presti D, Dall\u2019Olio FG, Besse B, Ribeiro JM, Di Meglio A, Soldato D (2022) Tumor infiltrating lymphocytes (TILs) as a predictive biomarker of response to checkpoint blockers in solid tumors: a systematic review. Crit Rev Oncol Hematol 177:103773. https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103773","journal-title":"Crit Rev Oncol Hematol"},{"key":"3985_CR84","doi-asserted-by":"publisher","first-page":"645242","DOI":"10.3389\/fimmu.2021.645242","volume":"12","author":"GO Rangel Rivera","year":"2021","unstructured":"Rangel Rivera GO, Knochelmann HM, Dwyer CJ, Smith AS, Wyatt MM, Rivera-Reyes AM, Thaxton JE, Paulos CM (2021) Fundamentals of T cell metabolism and strategies to enhance cancer immunotherapy. Front Immunol 12:645242. https:\/\/doi.org\/10.3389\/fimmu.2021.645242","journal-title":"Front Immunol"},{"issue":"1_Supplement","key":"3985_CR85","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4049\/jimmunol.206.Supp.53.10","volume":"206","author":"K Read","year":"2021","unstructured":"Read K, Sreekumar B, Powell MD, Jones DM, Pokhrel S, Saadey A, Collins P, Ghoneim H, Oestreich KJ (2021) Eos differentially regulates Th1 versus Tfh differentiation through feed-forward propagation of the IL-2\/STAT5 signaling pathway. J Immunol 206(1_Supplement):53\u201310. https:\/\/doi.org\/10.4049\/jimmunol.206.Supp.53.10","journal-title":"J Immunol"},{"key":"3985_CR86","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/978-3-031-70875-6_19","volume":"1464","author":"CH Rivas","year":"2025","unstructured":"Rivas CH, Liu F, Zhang XH (2025) The roles of myeloid cells in breast cancer progression. Adv Exp Med Biol 1464:397\u2013412. https:\/\/doi.org\/10.1007\/978-3-031-70875-6_19","journal-title":"Adv Exp Med Biol"},{"issue":"9","key":"3985_CR87","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.3390\/cancers16091615","volume":"16","author":"M Rossi","year":"2024","unstructured":"Rossi M, Radisky DC (2024) Multiplex digital spatial profiling in breast cancer research: state-of-the-art technologies and applications across the translational science spectrum. Cancers 16(9):1615. https:\/\/doi.org\/10.3390\/cancers16091615","journal-title":"Cancers"},{"key":"3985_CR88","doi-asserted-by":"publisher","first-page":"933113","DOI":"10.3389\/fcell.2022.933113","volume":"10","author":"A Rossi","year":"2022","unstructured":"Rossi A, Belmonte B, Carnevale S, Liotti A, De Rosa V, Jaillon S, Piconese S, Tripodo C (2022) Stromal and immune cell dynamics in tumor associated tertiary lymphoid structures and anti-tumor immune responses. Front Cell Dev Biol 10:933113. https:\/\/doi.org\/10.3389\/fcell.2022.933113","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"3985_CR89","doi-asserted-by":"publisher","first-page":"101184","DOI":"10.1016\/j.esmoop.2023.101184","volume":"8","author":"A Rousseau","year":"2023","unstructured":"Rousseau A, Parisi C, Barlesi F (2023) Anti-TIGIT therapies for solid tumors: a systematic review. ESMO Open 8(2):101184. https:\/\/doi.org\/10.1016\/j.esmoop.2023.101184","journal-title":"ESMO Open"},{"issue":"769","key":"3985_CR90","doi-asserted-by":"publisher","first-page":"eadj9331","DOI":"10.1126\/scitranslmed.adj9331","volume":"16","author":"X Rui","year":"2024","unstructured":"Rui X, Alvarez Calderon F, Wobma H, Gerdemann U, Albanese A, Cagnin L, McGuckin C, Michaelis KA, Naqvi K, Blazar BR, Tkachev V (2024) Human OX40L\u2013CAR-Tregs target activated antigen-presenting cells and control T cell alloreactivity. Sci Transl Med 16(769):eadj9331. https:\/\/doi.org\/10.1126\/scitranslmed.adj9331","journal-title":"Sci Transl Med"},{"issue":"2","key":"3985_CR91","doi-asserted-by":"publisher","first-page":"380","DOI":"10.14202\/vetworld.2023.380-385","volume":"16","author":"MJ Saadh","year":"2023","unstructured":"Saadh MJ (2023) Potential protective effects of red grape seed extract in a rat model of malathion-induced neurotoxicity. Vet World 16(2):380. https:\/\/doi.org\/10.14202\/vetworld.2023.380-385","journal-title":"Vet World"},{"key":"3985_CR92","doi-asserted-by":"publisher","first-page":"702726","DOI":"10.3389\/fimmu.2021.702726","volume":"12","author":"EN Scott","year":"2021","unstructured":"Scott EN, Gocher AM, Workman CJ, Vignali DA (2021) Regulatory T cells: barriers of immune infiltration into the tumor microenvironment. Front Immunol 12:702726. https:\/\/doi.org\/10.3389\/fimmu.2021.702726","journal-title":"Front Immunol"},{"issue":"5","key":"3985_CR93","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.3390\/biomedicines10051061","volume":"10","author":"J Solek","year":"2022","unstructured":"Solek J, Chrzanowski J, Cieslak A, Zielinska A, Piasecka D, Braun M, Sadej R, Romanska HM (2022) Subtype-specific tumour immune microenvironment in risk of recurrence of ductal carcinoma in situ: prognostic value of HER2. Biomedicines 10(5):1061. https:\/\/doi.org\/10.3390\/biomedicines10051061","journal-title":"Biomedicines"},{"issue":"15","key":"3985_CR94","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1042\/CS20220531","volume":"137","author":"Z Strizova","year":"2023","unstructured":"Strizova Z, Benesova I, Bartolini R, Novysedlak R, Cecrdlova E, Foley LK, Striz I (2023) M1\/M2 macrophages and their overlaps\u2013myth or reality? Clin Sci 137(15):1067\u20131093. https:\/\/doi.org\/10.1042\/CS20220531","journal-title":"Clin Sci"},{"key":"3985_CR95","doi-asserted-by":"publisher","first-page":"1349081","DOI":"10.3389\/fphar.2023.1349081","volume":"14","author":"J Su","year":"2024","unstructured":"Su J, Fu Y, Cui Z, Abidin Z, Yuan J, Zhang X, Li R, Zhao C (2024) Relatlimab: a novel drug targeting immune checkpoint LAG-3 in melanoma therapy. Front Pharmacol 14:1349081. https:\/\/doi.org\/10.3389\/fphar.2023.1349081","journal-title":"Front Pharmacol"},{"issue":"1","key":"3985_CR96","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.bbcan.2018.06.005","volume":"1870","author":"L Sun","year":"2018","unstructured":"Sun L, Suo C, Li ST, Zhang H, Gao P (2018) Metabolic reprogramming for cancer cells and their microenvironment: beyond the Warburg effect. Biochim Biophys Acta Revi Cancer 1870(1):51\u201366. https:\/\/doi.org\/10.1016\/j.bbcan.2018.06.005","journal-title":"Biochim Biophys Acta Revi Cancer"},{"key":"3985_CR97","doi-asserted-by":"publisher","first-page":"215823","DOI":"10.1016\/j.canlet.2022.215823","volume":"548","author":"Q Tang","year":"2022","unstructured":"Tang Q, Yang S, He G, Zheng H, Zhang S, Liu J, Wei S, Fan Q, Peng X, Li X, Zhang D (2022) Tumor-derived exosomes in the cancer immune microenvironment and cancer immunotherapy. Cancer Lett 548:215823. https:\/\/doi.org\/10.1016\/j.canlet.2022.215823","journal-title":"Cancer Lett"},{"key":"3985_CR98","doi-asserted-by":"publisher","first-page":"844866","DOI":"10.3389\/fimmu.2022.844866","volume":"13","author":"BC Taylor","year":"2022","unstructured":"Taylor BC, Balko JM (2022) Mechanisms of MHC-I downregulation and role in immunotherapy response. Front Immunol 13:844866. https:\/\/doi.org\/10.3389\/fimmu.2022.844866","journal-title":"Front Immunol"},{"issue":"30","key":"3985_CR99","doi-asserted-by":"publisher","first-page":"e2023739118","DOI":"10.1073\/pnas.2023739118","volume":"118","author":"M Tekguc","year":"2021","unstructured":"Tekguc M, Wing JB, Osaki M, Long J, Sakaguchi S (2021) Treg-expressed CTLA-4 depletes CD80\/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells. Proc Natl Acad Sci 118(30):e2023739118. https:\/\/doi.org\/10.1073\/pnas.2023739118","journal-title":"Proc Natl Acad Sci"},{"key":"3985_CR100","doi-asserted-by":"publisher","first-page":"731175","DOI":"10.3389\/fonc.2021.731175","volume":"11","author":"T Tian","year":"2021","unstructured":"Tian T, Li Z (2021) Targeting Tim-3 in cancer with resistance to PD-1\/PD-L1 blockade. Front Oncol 11:731175. https:\/\/doi.org\/10.3389\/fonc.2021.731175","journal-title":"Front Oncol"},{"key":"3985_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109979","author":"M Tufail","year":"2024","unstructured":"Tufail M, Hu JJ, Liang J, He CY, Wan WD, Huang YQ, Jiang CH, Wu H, Li N (2024) Hallmarks of cancer resistance. Iscience. https:\/\/doi.org\/10.1016\/j.isci.2024.109979","journal-title":"Iscience"},{"key":"3985_CR102","doi-asserted-by":"publisher","unstructured":"Viel S, Vivier E, Walzer T, Mar\u00e7ais A (2024) Targeting metabolic dysfunction of CD8 T cells and natural killer cells in cancer. Nat Rev Drug Discov 1\u20139. https:\/\/doi.org\/10.1038\/s41573-024-01098-w","DOI":"10.1038\/s41573-024-01098-w"},{"key":"3985_CR103","unstructured":"Volfson Sedletsky V (n.d.) Analysis of T cell subsets in systemic sclerosis patients reveals altered composition and features of dysfunction\u00a0(Doctoral dissertation)"},{"key":"3985_CR104","doi-asserted-by":"publisher","unstructured":"Wan J, Cheng C, Hu J, Huang H, Han Q, Jie Z, Zou Q, Shi JH, Yu X (2023) De novo NAD+ synthesis contributes to CD8+ T cell metabolic fitness and antitumor function. Cell Rep 42(12). https:\/\/doi.org\/10.1016\/j.celrep.2023.113518","DOI":"10.1016\/j.celrep.2023.113518"},{"issue":"4","key":"3985_CR105","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.3390\/cells9041011","volume":"9","author":"Y Wang","year":"2020","unstructured":"Wang Y, Jia A, Bi Y, Wang Y, Liu G (2020) Metabolic regulation of myeloid-derived suppressor cell function in cancer. Cells 9(4):1011. https:\/\/doi.org\/10.3390\/cells9041011","journal-title":"Cells"},{"key":"3985_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13020-021-00466-7","volume":"16","author":"J Wang","year":"2021","unstructured":"Wang J, Lu S, Yang F, Guo Y, Chen Z, Yu N, Yao L, Huang J, Fan W, Xu Z, Gong Y (2021) The role of macrophage polarization and associated mechanisms in regulating the anti-inflammatory action of acupuncture: a literature review and perspectives. Chin Med 16:1\u20136. https:\/\/doi.org\/10.1186\/s13020-021-00466-7","journal-title":"Chin Med"},{"key":"3985_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2023.06.001","author":"Y Wang","year":"2023","unstructured":"Wang Y, Huang T, Gu J, Lu L (2023) Targeting the metabolism of tumor-infiltrating regulatory T cells. Trends Immunol. https:\/\/doi.org\/10.1016\/j.it.2023.06.001","journal-title":"Trends Immunol"},{"issue":"1","key":"3985_CR108","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41698-024-00522-z","volume":"8","author":"S Wang","year":"2024","unstructured":"Wang S, Wang J, Chen Z, Luo J, Guo W, Sun L, Lin L (2024a) Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance. NPJ Precis Oncol 8(1):31. https:\/\/doi.org\/10.1038\/s41698-024-00522-z","journal-title":"NPJ Precis Oncol"},{"issue":"22","key":"3985_CR109","doi-asserted-by":"publisher","first-page":"12223","DOI":"10.3390\/ijms252212223","volume":"25","author":"J Wang","year":"2024","unstructured":"Wang J, He Y, Hu F, Hu C, Sun Y, Yang K, Yang S (2024b) Metabolic reprogramming of immune cells in the tumor microenvironment. Int J Mol Sci 25(22):12223. https:\/\/doi.org\/10.3390\/ijms252212223","journal-title":"Int J Mol Sci"},{"issue":"17","key":"3985_CR110","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.3390\/cancers16173069","volume":"16","author":"C Wang","year":"2024","unstructured":"Wang C, Tan JY, Chitkara N, Bhatt S (2024c) TP53 mutation-mediated immune evasion in cancer: mechanisms and therapeutic implications. Cancers 16(17):3069. https:\/\/doi.org\/10.3390\/cancers16173069","journal-title":"Cancers"},{"key":"3985_CR111","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3389\/fonc.2018.00284","volume":"8","author":"B Wegiel","year":"2018","unstructured":"Wegiel B, Vuerich M, Daneshmandi S, Seth P (2018) Metabolic switch in the tumor microenvironment determines immune responses to anti-cancer therapy. Front Oncol 8:284. https:\/\/doi.org\/10.3389\/fonc.2018.00284","journal-title":"Front Oncol"},{"issue":"13","key":"3985_CR112","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.3390\/cancers13133310","volume":"13","author":"Q Wright","year":"2021","unstructured":"Wright Q, Gonzalez Cruz JL, Wells JW, Leggatt GR (2021) PD-1 and beyond to activate T cells in cutaneous squamous cell cancers: the case for 4\u20131BB and VISTA antibodies in combination therapy. Cancers 13(13):3310. https:\/\/doi.org\/10.3390\/cancers13133310","journal-title":"Cancers"},{"issue":"5","key":"3985_CR113","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/cmi.2017.148","volume":"15","author":"W Xu","year":"2018","unstructured":"Xu W, Hi\u1ebfu T, Malarkannan S, Wang L (2018) The structure, expression, and multifaceted role of immune-checkpoint protein VISTA as a critical regulator of anti-tumor immunity, autoimmunity, and inflammation. Cell Mol Immunol 15(5):438\u2013446. https:\/\/doi.org\/10.1038\/cmi.2017.148","journal-title":"Cell Mol Immunol"},{"key":"3985_CR114","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.3389\/fimmu.2019.01399","volume":"10","author":"D Yan","year":"2019","unstructured":"Yan D, Adeshakin AO, Xu M, Afolabi LO, Zhang G, Chen YH, Wan X (2019) Lipid metabolic pathways confer the immunosuppressive function of myeloid-derived suppressor cells in tumor. Front Immunol 10:1399. https:\/\/doi.org\/10.3389\/fimmu.2019.01399","journal-title":"Front Immunol"},{"issue":"1","key":"3985_CR115","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13045-022-01322-3","volume":"15","author":"Y Yan","year":"2022","unstructured":"Yan Y, Huang L, Liu Y, Yi M, Chu Q, Jiao D, Wu K (2022) Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity. J Hematol Oncol 15(1):104. https:\/\/doi.org\/10.1186\/s13045-022-01322-3","journal-title":"J Hematol Oncol"},{"issue":"1","key":"3985_CR116","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13567-023-01209-2","volume":"54","author":"SW Yan","year":"2023","unstructured":"Yan SW, Zhang R, Guo X, Wang BN, Long SR, Liu RD, Wang ZQ, Cui J (2023) Trichinella spiralis dipeptidyl peptidase 1 suppressed macrophage cytotoxicity by promoting M2 polarization via the STAT6\/PPAR\u03b3 pathway. Vet Res 54(1):77. https:\/\/doi.org\/10.1186\/s13567-023-01209-2","journal-title":"Vet Res"},{"key":"3985_CR117","doi-asserted-by":"publisher","unstructured":"Yang L, Wang X, Wang S, Shen J, Li Y, Wan S, Xiao Z, Wu Z (2025) Targeting lipid metabolism in regulatory T cells for enhancing cancer immunotherapy. Biochim Biophys Acta Rev Cancer. 189259. https:\/\/doi.org\/10.1016\/j.bbcan.2025.189259","DOI":"10.1016\/j.bbcan.2025.189259"},{"issue":"5","key":"3985_CR118","first-page":"1952","volume":"13","author":"PH Ye","year":"2023","unstructured":"Ye PH, Li CY, Cheng HY, Anuraga G, Wang CY, Chen FW, Yang SJ, Lee KT, Chang KY, Lai MD (2023) A novel combination therapy of arginine deiminase and an arginase inhibitor targeting arginine metabolism in the tumor and immune microenvironment. Am J Cancer Res 13(5):1952","journal-title":"Am J Cancer Res"},{"issue":"1","key":"3985_CR119","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12943-023-01885-w","volume":"22","author":"M Yi","year":"2023","unstructured":"Yi M, Li T, Niu M, Mei Q, Zhao B, Chu Q, Dai Z, Wu K (2023) Exploiting innate immunity for cancer immunotherapy. Mol Cancer 22(1):187. https:\/\/doi.org\/10.1186\/s12943-023-01885-w","journal-title":"Mol Cancer"},{"issue":"13","key":"3985_CR120","doi-asserted-by":"publisher","first-page":"2300665","DOI":"10.1002\/adma.202300665","volume":"36","author":"K Yi","year":"2024","unstructured":"Yi K, Kong H, Lao YH, Li D, Mintz RL, Fang T, Chen G, Tao Y, Li M, Ding J (2024) Engineered nanomaterials to potentiate CRISPR\/Cas9 gene editing for cancer therapy. Adv Mater 36(13):2300665. https:\/\/doi.org\/10.1002\/adma.202300665","journal-title":"Adv Mater"},{"issue":"24","key":"3985_CR121","doi-asserted-by":"publisher","first-page":"6175","DOI":"10.7150\/jca.35901","volume":"10","author":"SC Zhang","year":"2019","unstructured":"Zhang SC, Hu ZQ, Long JH, Zhu GM, Wang Y, Jia Y, Zhou J, Ouyang Y, Zeng Z (2019) Clinical implications of tumor-infiltrating immune cells in breast cancer. J Cancer 10(24):6175. https:\/\/doi.org\/10.7150\/jca.35901","journal-title":"J Cancer"},{"key":"3985_CR122","doi-asserted-by":"publisher","first-page":"678355","DOI":"10.3389\/fimmu.2021.678355","volume":"12","author":"S Zhang","year":"2021","unstructured":"Zhang S, Gang X, Yang S, Cui M, Sun L, Li Z, Wang G (2021a) The alterations in and the role of the Th17\/Treg balance in metabolic diseases. Front Immunol 12:678355. https:\/\/doi.org\/10.3389\/fimmu.2021.678355","journal-title":"Front Immunol"},{"issue":"4","key":"3985_CR123","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1007\/s12282-021-01247-8","volume":"28","author":"J Zhang","year":"2021","unstructured":"Zhang J, Tian Q, Zhang M, Wang H, Wu L, Yang J (2021b) Immune-related biomarkers in triple-negative breast cancer. Breast Cancer 28(4):792\u2013805. https:\/\/doi.org\/10.1007\/s12282-021-01247-8","journal-title":"Breast Cancer"},{"issue":"6","key":"3985_CR124","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/jcb.30403","volume":"124","author":"M Zhang","year":"2023","unstructured":"Zhang M, Wu Z, Salas SS, Aguilar MM, Trillos-Almanza MC, Buist-Homan M, Moshage H (2023a) Arginase 1 expression is increased during hepatic stellate cell activation and facilitates collagen synthesis. J Cell Biochem 124(6):808\u2013817. https:\/\/doi.org\/10.1002\/jcb.30403","journal-title":"J Cell Biochem"},{"issue":"3","key":"3985_CR125","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.21037\/jtd-23-227","volume":"15","author":"C Zhang","year":"2023","unstructured":"Zhang C, Xu L, Ma Y, Huang Y, Zhou L, Le H, Chen Z (2023b) Increased TIM-3 expression in tumor-associated macrophages predicts a poorer prognosis in non-small cell lung cancer: a retrospective cohort study. J Thorac Dis 15(3):1433. https:\/\/doi.org\/10.21037\/jtd-23-227","journal-title":"J Thorac Dis"},{"issue":"1","key":"3985_CR126","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s40364-024-00646-1","volume":"12","author":"H Zhang","year":"2024","unstructured":"Zhang H, Li S, Wang D, Liu S, Xiao T, Gu W, Yang H, Wang H, Yang M, Chen P (2024) Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment. Biomark Res 12(1):96. https:\/\/doi.org\/10.1186\/s40364-024-00646-1","journal-title":"Biomark Res"},{"issue":"1","key":"3985_CR127","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","volume":"6","author":"H Zhao","year":"2021","unstructured":"Zhao H, Wu L, Yan G, Chen Y, Zhou M, Wu Y, Li Y (2021) Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduct Target Ther 6(1):263. https:\/\/doi.org\/10.1038\/s41392-021-00658-5","journal-title":"Signal Transduct Target Ther"},{"issue":"13","key":"3985_CR128","doi-asserted-by":"publisher","first-page":"5109","DOI":"10.7150\/ijbs.99680","volume":"20","author":"X Zhao","year":"2024","unstructured":"Zhao X, Ren T, Li S, Wang X, Hou R, Guan Z, Liu D, Zheng J, Shi M (2024) A new perspective on the therapeutic potential of tumor metastasis: targeting the metabolic interactions between TAMs and tumor cells. Int J Biol Sci 20(13):5109. https:\/\/doi.org\/10.7150\/ijbs.99680","journal-title":"Int J Biol Sci"},{"issue":"1","key":"3985_CR129","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s40164-024-00543-1","volume":"13","author":"S Zheng","year":"2024","unstructured":"Zheng S, Wang W, Shen L, Yao Y, Xia W, Ni C (2024) Tumor battlefield within inflamed, excluded or desert immune phenotypes: the mechanisms and strategies. Exp Hematol Oncol 13(1):80. https:\/\/doi.org\/10.1186\/s40164-024-00543-1","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"3985_CR130","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41467-021-27690-x","volume":"13","author":"M Zhou","year":"2022","unstructured":"Zhou M, Coruh C, Xu G, Martins LM, Bourbousse C, Lambolez A, Law JA (2022) The CLASSY family controls tissue-specific DNA methylation patterns in Arabidopsis. Nat Commun 13(1):244. https:\/\/doi.org\/10.1038\/s41467-021-27690-x","journal-title":"Nat Commun"},{"issue":"10","key":"3985_CR131","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.3390\/cancers15102718","volume":"15","author":"DC Ziogas","year":"2023","unstructured":"Ziogas DC, Theocharopoulos C, Lialios PP, Foteinou D, Koumprentziotis IA, Xynos G, Gogas H (2023) Beyond CTLA-4 and PD-1 inhibition: novel immune checkpoint molecules for melanoma treatment. Cancers 15(10):2718. https:\/\/doi.org\/10.3390\/cancers15102718","journal-title":"Cancers"},{"key":"3985_CR132","doi-asserted-by":"publisher","first-page":"1387975","DOI":"10.3389\/fimmu.2024.1387975","volume":"15","author":"Y Zong","year":"2024","unstructured":"Zong Y, Deng K, Chong WP (2024) Regulation of Treg cells by cytokine signaling and co-stimulatory molecules. Front Immunol 15:1387975. https:\/\/doi.org\/10.3389\/fimmu.2024.1387975","journal-title":"Front Immunol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-03985-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-03985-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-03985-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T09:57:05Z","timestamp":1755079025000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-03985-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":132,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["3985"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-03985-4","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,10]]},"assertion":[{"value":"1 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Since this review article is based on the literature and does not include patients or experimental animals, the ethics approval and consent do not apply.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}